Immatics (IMTX) Interest Income - Net (2019 - 2025)
Immatics (IMTX) posted Interest Income - Net of -$45.1 million for Q4 2025, down 965.7% sequentially from -$4.2 million in Q3 2025, and down 541.2% YoY from $10.2 million in Q4 2024.
Immatics (IMTX) Interest Income - Net (2019 - 2025) Analysis & Trends
Immatics has reported Interest Income - Net for 7 years, with the latest figure at -$45.1 million in Q4 2025.
- Quarterly Interest Income - Net fell 541.2% year-over-year to -$45.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$71.7 million (down 470.39% YoY) and the FY2025 annual result came in at -$60.8 million, down 137.36% from the prior year.
- Interest Income - Net eased to -$45.1 million in Q4 2025 per IMTX's latest filing, from -$4.2 million in the prior quarter.
- Over five years, Interest Income - Net peaked at $8.3 million in Q1 2025 and troughed at -$45.1 million in Q4 2025.
- A 5-year average of -$3.9 million and a median of $12834.9 in 2021 frame the typical range for Interest Income - Net.
- The sharpest annual moves came in 2022 and 2023: Interest Income - Net surged 1248.05% in 2022, then slumped 1563.5% in 2023.
- Over 5 years, Interest Income - Net stood at $337471.4 in 2021, then soared by 1248.05% to $4.5 million in 2022, then sank by 59.36% to $1.8 million in 2023, then slumped by 480.59% to -$7.0 million in 2024, then plunged by 541.2% to -$45.1 million in 2025.
- According to Business Quant data, Interest Income - Net over the past three periods registered -$45.1 million, -$4.2 million, and -$30.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 38.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.11 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Jun 30, 2025 | -30.60 Mn |
| Mar 31, 2025 | 8.28 Mn |
| Dec 31, 2024 | -7.04 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | -7.18 Mn |
| Mar 31, 2024 | -6.10 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | -2.63 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 4.55 Mn |
| Sep 30, 2022 | -158,299.07 |
| Jun 30, 2022 | -452,432.04 |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 337,471.43 |
| Sep 30, 2021 | 183,968.82 |
| Jun 30, 2021 | 711,724.42 |
| Mar 31, 2021 | 1.42 Mn |